January 2018 - TheraCann

On January 25, 2018, Health Canada updated the security requirements for Licenced Producers under the Access to Cannabis for Medical Purposes Regulations (ACMPR). This amendment to the regulations makes substantive changes to the storage area(s) for current licensed producers and applicants, including re-classification of which was previously the ‘vault’.  As per the Security Directive the

STONY BROOK N.Y. (January 25th, 2018) – Applied DNA Sciences, Inc. (NASDAQ: APDN, “Applied DNA,” “the Company”) today announced the signing of an initial two-year, $1 million contract with TheraCann International Benchmark Corporation, (“TheraCann”), a leading full service cannabis consultancy with operations in the US, Canada, Australia, Europe and South America, for the integration of the Company’s SigNature® molecular

Las Vegas, Nevada – December 21th, 2017 – Tokes Platform, a leader in providing blockchain solutionsfor the cannabis industry, and TheraCann International Benchmark Corporation, a leading full serviceinternational cannabis consultancy (“TheraCann”), is pleased to announce today they have entered intoa strategic partnership. Chris Bolton, chief operating officer of TheraCann International, says “We were impressed early

Calgary, Alberta Canada – January 2nd, 2018 – TheraCann International Benchmark Corporation, a leading full service international cannabis consultancy (“TheraCann”), announced today TheraCann Canada a wholly owned subsidiary of TheraCann International Benchmark Corporation and Maple Leaf Green World Ltd. (MLGW) have settled all litigation related to their licencing and service dispute. This settlement ends all